Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilot

Apogee details its $10.9B AbbVie buyout, the UK launches a drug-pricing pilot, and Brii shares Phase 2b HBV vaccine data.

Raccontata daendpoints.news